Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBP5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,209
Award facts
- Contract value 100% obligated
- $47,209.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $47,209 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The delivery order, issued on December 4, 2025, with completion targeted for December 26, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group is the sole contractor on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy designed to support Department of Defense pharmaceutical supply requirements globally. The parent contract, awarded November 13, 2025, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. The delivery order reflects the company's ongoing role as a critical supplier within the federal pharmaceutical supply chain, leveraging its established performance and diverse product portfolio to support DoD medical operations.
Quick answers
Who was awarded contract SPE2DR26FFBP5?
SPE2DR26FFBP5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FFBP5 worth?
The government has obligated $47,209 on SPE2DR26FFBP5.
Is contract SPE2DR26FFBP5 an order under another contract?
Yes. SPE2DR26FFBP5 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBP5 competed?
The extent of competition for SPE2DR26FFBP5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award